RBM39 and acute myeloid leukemia: On the other hand, the identification of RBM39 as a dependency molecule in AML, for example, is a promising result as RBM39 is directly targeted by sulfonamides, providing a unique example of translation from a basic RBP screen to the development of pharmacological intervention against malignancies.